CEO: Sharon Mates

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders.


Key numbers

Market Capitalization:498454220
Shares Outstanding: 55261000
Float: 46640449.783
Next Earning Date:2020-02-25
TTm EPS: -2.6868
TTm Dividend Rate:
200 days moving average:11.12
50 days moving average: 8.76
One day percent Change: 5.45



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,